Concord Medical Services ADR
(CCM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -89,333 | -74,795 | -111,492 | -82,020 | -61,922 |
| Depreciation Amortization | 17,914 | 18,093 | 19,256 | 16,332 | 12,307 |
| Income taxes - deferred | -2,144 | -1,837 | -10,417 | 1,766 | -2,046 |
| Accounts receivable | 1,646 | 5,134 | 93 | -10,114 | -945 |
| Accounts payable and accrued liabilities | 12,748 | 2,222 | 16,491 | 41,246 | 1,704 |
| Other Working Capital | -20,459 | -7,750 | 15,228 | -7,313 | -4,996 |
| Other Operating Activity | 25,137 | 19,989 | 39,422 | -16,284 | 20,686 |
| Operating Cash Flow | $-54,491 | $-38,944 | $-31,419 | $-56,387 | $-35,212 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17,444 | N/A | 1,732 | 3,135 | -7,200 |
| PPE Investments | -54,891 | -15,872 | -31,512 | -10,358 | -25,709 |
| Net Acquisitions | 1,241 | N/A | N/A | 246 | 29,612 |
| Purchase Of Investment | -13,974 | -14 | -333 | -10,607 | -29,476 |
| Sale Of Investment | 3,790 | 8,451 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,392 | -593 | -150 | -3,093 | -1,257 |
| Other Investing Activity | -22 | 720 | 12,890 | -71,231 | -49,049 |
| Investing Cash Flow | $-81,300 | $-6,715 | $-17,223 | $-88,815 | $-81,822 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 110,317 | 50,683 | 63,481 | 23,624 | 117,547 |
| Debt Issued | 72,056 | 15,493 | 61,295 | 63,809 | 131,358 |
| Debt Repayment | N/A | -1,065 | -28,563 | -32,335 | -37,061 |
| Common Stock Issued | 69,941 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -95,309 | -28,821 | -40,671 | 45,715 | -37,390 |
| Financing Cash Flow | $157,005 | $36,290 | $55,542 | $100,813 | $174,454 |
| Exchange Rate Effect | -1,134 | -338 | -6,837 | -723 | -394 |
| Beginning Cash Position | 12,387 | 22,443 | 23,040 | 70,049 | 11,388 |
| End Cash Position | 32,467 | 12,736 | 23,103 | 24,937 | 68,414 |
| Net Cash Flow | $20,080 | $-9,707 | $63 | $-45,112 | $57,026 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,491 | -38,944 | -31,419 | -56,387 | -35,212 |
| Capital Expenditure | -20,656 | -15,916 | -32,329 | -43,778 | -25,751 |
| Free Cash Flow | -75,147 | -54,860 | -63,748 | -100,165 | -60,963 |